Rimifon and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Rimifon (isoniazid), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Rifadin, and have Hiv infection.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Rimifon. It is created by eHealthMe based on reports of 925 people who have side effects when taking Rimifon from the FDA, and is updated regularly.

What is Rimifon?

Rimifon has active ingredients of isoniazid. eHealthMe is studying from 925 Rimifon users. Check the latest studies of Rimifon.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,835 drugs and 4,492 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Jul, 19, 2026

925 people reported to have side effects when taking Rimifon.
Among them, 87 people (9.41%) have Acute kidney failure.

Could Rimifon cause Acute kidney failure?

Among these 87 people:

How long have people been on Rimifon when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Rimifon? *

female: 16.28 %
male: 83.72 %

What is the age of people who have Acute kidney failure when taking Rimifon? *

What are other drugs people take besides Rimifon? *

What are other side effects people have besides Acute kidney failure? *

Fever: 18 people, 20.69%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 17 people, 19.54%
Dyspnea (difficult or laboured breathing): 12 people, 13.79%
Erythema Multiforme (a type of hypersensitivity reaction): 12 people, 13.79%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 11 people, 12.64%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 10 people, 11.49%
Pleural Effusion (water on the lungs): 10 people, 11.49%
General Physical Health Deterioration (weak health status): 10 people, 11.49%
Immune Reconstitution Syndrome (immune recovery syndrome): 10 people, 11.49%
Altered State Of Consciousness (altered state of mind): 10 people, 11.49%

What are the existing conditions these people have? *

Hiv Infection: 39 people, 44.83%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 37 people, 42.53%
Pulmonary Tuberculosis (lungs tuberculosis): 14 people, 16.09%
Rashes (redness): 8 people, 9.20%
High Blood Pressure: 6 people, 6.90%
Aspergillosis (an infection caused by a fungus called aspergillus): 6 people, 6.90%
Cytomegalovirus Infection: 6 people, 6.90%
Mycobacterium Avium Complex Infection: 6 people, 6.90%
Diarrhea: 6 people, 6.90%
Fungal Infection: 6 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Rimifon and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rimifon:

Rimifon (925 reports)

Browse all side effects of Rimifon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,835 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,492 conditions)

Related publications that referenced our studies

Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .
Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on isoniazid (the active ingredients of Rimifon) and Rimifon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.